Financial Architects (New Jersey)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-160
Closed -$16K – 1497
2017
Q3
$16K Hold
160
– – ﹤0.01% 1011
2017
Q2
$16K Sell
160
-72
-31% -$7.76K ﹤0.01% 1020
2017
Q1
$27K Sell
232
-12
-5% -$1.4K ﹤0.01% 850
2016
Q4
$29K Buy
244
+74
+44% +$8.19K 0.01% 730
2016
Q3
$19K Buy
170
+16
+10% +$1.84K 0.01% 854
2016
Q2
$19K Hold
154
– – 0.01% 798
2016
Q1
$17K Buy
+154
New +$16K 0.01% 617
2015
Q3
– Sell
-154
Closed -$18K – 334
2015
Q2
$18K Hold
154
– – 0.01% 661
2015
Q1
$16K Buy
+154
New +$16.4K 0.01% 614

Other funds holding CLB

Financial Architects (New Jersey)'s CLB Position: Q4 2017 in Review

Financial Architects (New Jersey) sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 160 shares — an estimated $16K sold.

Financial Architects (New Jersey) first reported a position in CLB in Q1 2015 and held it in 9 quarters. The position peaked at $29K in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Financial Architects (New Jersey) reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 160 Core Laboratories shares in Q4 2017, an estimated $16K.
  • Financial Architects (New Jersey) first reported a position in Core Laboratories in Q1 2015 and held it in 9 quarters.
  • Financial Architects (New Jersey)'s Core Laboratories position peaked at $29K in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2017, filed 12 Feb 2018.